← Eichor
Study identifier: NCT04481321 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clinical and Molecular Study of Endometriosis and Adenomyosis

Condition: Endometriosis · Adenomyosis  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseN/A
Planned participants5300
Who can joinFemale, 18 Years to 42 Years
Healthy volunteersNo

About this study

The purpose of this study is to determine whether endometriosis and adenomyosis are progressive diseases, in terms of symptoms (pain, abnormal uterine bleeding and infertility), anatomical lesions size, and recurrences. We also aimed to address molecular questions on immune dialogues between ectopic lesions and the eutopic endometrium, auto-immunity in endometriosis and adenomyosis and the role of the microbiota in their respective pathophysiologies.

This description comes directly from the study's public registry record.

Talk to the study team

Charles Chapron, MD  ·  1 58 41 19 33  ·  charles.chapron@aphp.fr

Laurence Lecomte, PhD  ·  1 58 41 34 78  ·  laurence.lecomte@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Port Royal, hospital cochinParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04481321